흡입용 일산화질소 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Inhaled Nitric Oxide was estimated to be worth US$ 649 million in 2024 and is forecast to a readjusted size of US$ 940 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Inhaled Nitric Oxide cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Inhaled Nitric Oxide (iNO) is a gas therapy widely used in the treatment of respiratory diseases, particularly neonatal respiratory distress syndrome (NRDS) and acute respiratory distress syndrome (ARDS) in adults. As a vasodilator, nitric oxide works by dilating the small blood vessels in the lungs, improving the matching of ventilation and blood flow in the alveoli, which in turn enhances oxygenation and reduces pulmonary arterial pressure. The therapeutic mechanism of inhaled nitric oxide primarily relies on its direct action on the smooth muscle of the pulmonary vessels, promoting the release of nitric oxide and thereby improving the vessel's ability to dilate, effectively improving the patient's oxygenation and respiratory function.

Currently, the products of inhaled nitric oxide mainly consist of gas formulations and related delivery devices, such as inhalers and gas concentration regulation systems. These products have been approved in many countries and regions and are widely used in neonatal intensive care units (NICU), adult ICUs, and emergency departments. With the increasing clinical demand, the application of inhaled nitric oxide in various respiratory diseases has a promising future, especially in promoting recovery in patients with acute lung injury.

The inhaled nitric oxide market continues to grow globally, driven by several factors. Firstly, with the rising incidence of respiratory diseases, particularly in neonatal and elderly populations, the demand for inhaled nitric oxide is increasing. Inhaled nitric oxide can significantly improve clinical symptoms in patients with acute respiratory distress syndrome and other pulmonary diseases, shorten hospital stays, and improve quality of life, thereby generating strong market demand.

Secondly, technological advancements are driving market growth. New delivery devices continue to emerge, enhancing the therapeutic efficacy and safety of inhaled nitric oxide. For example, convenient gas concentration regulation systems allow patients to precisely control their inhaled dosage, thus reducing side effects. Additionally, clinical research has shown that inhaled nitric oxide is effective not only in neonates but also in adult critically ill patients, demonstrating promising therapeutic potential.

However, the market also faces some challenges and risks. Firstly, the high cost of inhaled nitric oxide remains a significant barrier to widespread adoption, particularly in developing countries, where the expensive treatment cost limits its accessibility. Secondly, while inhaled nitric oxide has been widely used in treating specific diseases, its efficacy and safety still require further clinical data, especially in atypical cases.

The market concentration is relatively high, dominated by a few leading pharmaceutical and medical device companies, which have extensive experience in product development, marketing, and clinical trials. In the future, as technology advances and treatment methods become more widespread, market concentration may decrease. The downstream demand trend reflects a growing need for more personalized and efficient treatment methods, driving the development of customized devices and new drugs.

This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhaled Nitric Oxide by region & country, by Type, and by Application.

The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.

Market Segmentation

By Company

• Mallinckrodt (INOmax)
• Linde (Noxivent)
• Air Liquide (KINOX)

Segment by Type

• High Purity iNO
• Standard Purity iNO

Segment by Application

• Infants PPHN
• ARDS
• Other Diseases

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Inhaled Nitric Oxide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Inhaled Nitric Oxide in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Inhaled Nitric Oxide Product Introduction
• 1.2 Global Inhaled Nitric Oxide Market Size Forecast
  • 1.2.1 Global Inhaled Nitric Oxide Sales Value (2020-2031)
  • 1.2.2 Global Inhaled Nitric Oxide Sales Volume (2020-2031)
  • 1.2.3 Global Inhaled Nitric Oxide Sales Price (2020-2031)
• 1.3 Inhaled Nitric Oxide Market Trends & Drivers
  • 1.3.1 Inhaled Nitric Oxide Industry Trends
  • 1.3.2 Inhaled Nitric Oxide Market Drivers & Opportunity
  • 1.3.3 Inhaled Nitric Oxide Market Challenges
  • 1.3.4 Inhaled Nitric Oxide Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Inhaled Nitric Oxide Players Revenue Ranking (2024)
• 2.2 Global Inhaled Nitric Oxide Revenue by Company (2020-2025)
• 2.3 Global Inhaled Nitric Oxide Players Sales Volume Ranking (2024)
• 2.4 Global Inhaled Nitric Oxide Sales Volume by Company Players (2020-2025)
• 2.5 Global Inhaled Nitric Oxide Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Inhaled Nitric Oxide Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Inhaled Nitric Oxide Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Inhaled Nitric Oxide
• 2.9 Inhaled Nitric Oxide Market Competitive Analysis
  • 2.9.1 Inhaled Nitric Oxide Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Inhaled Nitric Oxide Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 High Purity iNO
  • 3.1.2 Standard Purity iNO
• 3.2 Global Inhaled Nitric Oxide Sales Value by Type
  • 3.2.1 Global Inhaled Nitric Oxide Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Inhaled Nitric Oxide Sales Value, by Type (2020-2031)
  • 3.2.3 Global Inhaled Nitric Oxide Sales Value, by Type (%) (2020-2031)
• 3.3 Global Inhaled Nitric Oxide Sales Volume by Type
  • 3.3.1 Global Inhaled Nitric Oxide Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Inhaled Nitric Oxide Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Inhaled Nitric Oxide Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Inhaled Nitric Oxide Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Infants PPHN
  • 4.1.2 ARDS
  • 4.1.3 Other Diseases
• 4.2 Global Inhaled Nitric Oxide Sales Value by Application
  • 4.2.1 Global Inhaled Nitric Oxide Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Inhaled Nitric Oxide Sales Value, by Application (2020-2031)
  • 4.2.3 Global Inhaled Nitric Oxide Sales Value, by Application (%) (2020-2031)
• 4.3 Global Inhaled Nitric Oxide Sales Volume by Application
  • 4.3.1 Global Inhaled Nitric Oxide Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Inhaled Nitric Oxide Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Inhaled Nitric Oxide Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Inhaled Nitric Oxide Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Inhaled Nitric Oxide Sales Value by Region
  • 5.1.1 Global Inhaled Nitric Oxide Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Inhaled Nitric Oxide Sales Value by Region (2020-2025)
  • 5.1.3 Global Inhaled Nitric Oxide Sales Value by Region (2026-2031)
  • 5.1.4 Global Inhaled Nitric Oxide Sales Value by Region (%), (2020-2031)
• 5.2 Global Inhaled Nitric Oxide Sales Volume by Region
  • 5.2.1 Global Inhaled Nitric Oxide Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Inhaled Nitric Oxide Sales Volume by Region (2020-2025)
  • 5.2.3 Global Inhaled Nitric Oxide Sales Volume by Region (2026-2031)
  • 5.2.4 Global Inhaled Nitric Oxide Sales Volume by Region (%), (2020-2031)
• 5.3 Global Inhaled Nitric Oxide Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Inhaled Nitric Oxide Sales Value, 2020-2031
  • 5.4.2 North America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Inhaled Nitric Oxide Sales Value, 2020-2031
  • 5.5.2 Europe Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Inhaled Nitric Oxide Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Inhaled Nitric Oxide Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Inhaled Nitric Oxide Sales Value, 2020-2031
  • 5.7.2 South America Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Inhaled Nitric Oxide Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Inhaled Nitric Oxide Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Inhaled Nitric Oxide Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Inhaled Nitric Oxide Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Inhaled Nitric Oxide Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.3.2 United States Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.4.2 Europe Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.5.2 China Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.6.2 Japan Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.7.2 South Korea Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Inhaled Nitric Oxide Sales Value, 2020-2031
  • 6.9.2 India Inhaled Nitric Oxide Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Inhaled Nitric Oxide Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Mallinckrodt (INOmax)
  • 7.1.1 Mallinckrodt (INOmax) Company Information
  • 7.1.2 Mallinckrodt (INOmax) Introduction and Business Overview
  • 7.1.3 Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Mallinckrodt (INOmax) Inhaled Nitric Oxide Product Offerings
  • 7.1.5 Mallinckrodt (INOmax) Recent Development
• 7.2 Linde (Noxivent)
  • 7.2.1 Linde (Noxivent) Company Information
  • 7.2.2 Linde (Noxivent) Introduction and Business Overview
  • 7.2.3 Linde (Noxivent) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Linde (Noxivent) Inhaled Nitric Oxide Product Offerings
  • 7.2.5 Linde (Noxivent) Recent Development
• 7.3 Air Liquide (KINOX)
  • 7.3.1 Air Liquide (KINOX) Company Information
  • 7.3.2 Air Liquide (KINOX) Introduction and Business Overview
  • 7.3.3 Air Liquide (KINOX) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Air Liquide (KINOX) Inhaled Nitric Oxide Product Offerings
  • 7.3.5 Air Liquide (KINOX) Recent Development

8 Industry Chain Analysis

• 8.1 Inhaled Nitric Oxide Industrial Chain
• 8.2 Inhaled Nitric Oxide Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Inhaled Nitric Oxide Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Inhaled Nitric Oxide Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer